Biotech Firm Amyris Hit with $881M Suit over Cannabinoid IP
By Willis Jacobson
Sep 17, 2020
Sep 17, 2020
A cannabinoid manufacturer has sued biotech company Amyris for $881M, amid a fraught 18-months relationship between the companies. Among other allegations, the lawsuit claims Amyris used the partnership to artificially inflate its own value and then leveraged the plaintiff’s trade...
This content is FREE for registered users.
To view this content you need to register as a Weedweek member.
If you are already a member please login below.
EXCLUSIVE: Rumors swirl as brands depart Herbl
On Wednesday, the founders of California brand Kikoko sent out an email announcing they had parted ways with distributor Herbl, “effective immediately.”“While this change feels abrupt,” Jennifer Chapin and Amanda...
Leafly removes stories about Trulieve factory worker’s death
Web site Leafly took down two stories investigating the death of a Trulieve factory worker in Massachusetts. Lorna McMurrey, 27, died at a hospital in January 2022 after she collapsed during...
Why doesn’t Calif. crack down on burner distros?
In recent weeks, a brash weed boss has alleged that Glass House, the company building California’s largest cannabis farm, is the “biggest black marketeer” in American history.In videos posted on...